UnitedHealth Group (NYSE:UNH) PT Raised to $405.00

UnitedHealth Group (NYSE:UNH) had its price objective raised by research analysts at Raymond James from $355.00 to $405.00 in a research report issued on Wednesday, The Fly reports. The firm currently has a “strong-buy” rating on the healthcare conglomerate’s stock. Raymond James’ price objective points to a potential upside of 16.15% from the company’s current price.

A number of other brokerages have also recently issued reports on UNH. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $384.00 to $389.00 and gave the company an “outperform” rating in a report on Thursday, October 15th. SVB Leerink upped their price target on shares of UnitedHealth Group from $373.00 to $378.00 and gave the stock an “outperform” rating in a report on Wednesday. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, October 19th. Piper Sandler boosted their target price on UnitedHealth Group from $385.00 to $409.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 11th. Finally, Cantor Fitzgerald raised their price target on UnitedHealth Group from $360.00 to $375.00 and gave the company an “overweight” rating in a report on Wednesday. Six analysts have rated the stock with a hold rating, nineteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $370.96.

Shares of NYSE UNH opened at $348.68 on Wednesday. UnitedHealth Group has a twelve month low of $187.72 and a twelve month high of $367.95. The stock’s 50 day moving average price is $334.54 and its 200-day moving average price is $312.22. The company has a market capitalization of $330.83 billion, a PE ratio of 20.03, a PEG ratio of 1.53 and a beta of 0.68. The company has a quick ratio of 0.84, a current ratio of 0.82 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, topping analysts’ consensus estimates of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The company had revenue of $65.12 billion for the quarter, compared to analysts’ expectations of $63.97 billion. During the same quarter in the previous year, the firm posted $3.88 EPS. UnitedHealth Group’s revenue was up 7.9% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group will post 16.78 EPS for the current fiscal year.

In related news, Director Stephen J. Hemsley sold 98,579 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $329.47, for a total value of $32,478,823.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.80% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Plancorp LLC increased its position in shares of UnitedHealth Group by 13.8% during the second quarter. Plancorp LLC now owns 9,530 shares of the healthcare conglomerate’s stock valued at $2,811,000 after acquiring an additional 1,158 shares in the last quarter. O Shares Investment Advisers LLC boosted its holdings in UnitedHealth Group by 13.0% in the second quarter. O Shares Investment Advisers LLC now owns 41,058 shares of the healthcare conglomerate’s stock worth $12,110,000 after purchasing an additional 4,728 shares during the last quarter. Aevitas Wealth Management Inc. boosted its holdings in UnitedHealth Group by 18.4% in the third quarter. Aevitas Wealth Management Inc. now owns 2,280 shares of the healthcare conglomerate’s stock worth $711,000 after purchasing an additional 354 shares during the last quarter. Alley Co LLC purchased a new stake in UnitedHealth Group in the third quarter worth approximately $204,000. Finally, Meiji Yasuda Asset Management Co Ltd. boosted its holdings in UnitedHealth Group by 20.8% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 51,371 shares of the healthcare conglomerate’s stock worth $15,152,000 after purchasing an additional 8,855 shares during the last quarter. 86.39% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Read More: Asset Allocation and Your Retirement

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.